New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
May 23, 2023 08:46 ET
|
Neuronetics
MALVERN, Pa., May 23, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
May 15, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Present at the JMP Securities Life Sciences Conference
May 09, 2023 17:00 ET
|
Neuronetics
MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
Neuronetics Reports Record First Quarter 2023 Financial and Operating Results
May 09, 2023 07:30 ET
|
Neuronetics
MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming...
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
May 08, 2023 08:47 ET
|
Neuronetics
MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., May 05, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting
May 03, 2023 08:58 ET
|
Neuronetics
MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month
May 02, 2023 09:01 ET
|
Neuronetics
A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
May 01, 2023 08:46 ET
|
Neuronetics
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Access through United HealthCare
April 28, 2023 16:11 ET
|
Neuronetics
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...